The aim of the COVend project is to deliver a new effective therapy against endothelial damage in ARDS for the clinical management of COVID-19 and other diseases. Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them. All posts reflect the views of COVend only
| Website | https://covend-project.eu/ |
| Employees | 3 (1 on RocketReach) |
| Industry | Research |
| Keywords | European Union Funding, Covid19 Treatment, Clinical Trials, Respiratory Therapy, Clinical Management, Drug Development, Pharmaceutical Research, Biomedical Research, Disease Treatment, Innovative Therapies, Health Innovation, Medical Research, Therapeutic Solutions, Lung Disease, Respiratory Diseases, Critical Care |
Looking for a particular COVend employee's phone or email?
COVend Questions
Conor Claxton is the CEO of COVend.
1 people are employed at COVend.
Top COVend Employees
Related Companies
G2Crowd Trusted
300K+
Plugin Users
